Ireland ETF in Focus on S&P Upgrade - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 9:00AM CDT
Inside the Ireland ETF after its latest upgrade from Standard and Poors.
Play the PIIGS Recovery with These European ETFs - ETF News And Commentary
Zacks Equity Research - ZACKS - Mon Mar 31, 9:01AM CDT
This group of country ETFs has been soaring and could be a solid choice for investors seeking Europe exposure.
Buy Ireland ETF for a Green Portfolio on St Patricks Day - ETF News And Commentary
Sweta Killa - ZACKS - Fri Mar 14, 1:00PM CDT
Investors can try the Ireland ETF for some hidden luck on St Patricks Day.
3 ETFs Crushing Eurozone Competition - ETF News And Commentary
Sweta Killa - ZACKS - Wed Mar 12, 1:00PM CDT
Recovery in the Euro zone remains on track with these ETFs leading the way.
Euro Zone Recovery Puts Ireland ETF in Focus - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 1:01PM CST
Could it be time to look at this European ETF for top ranked exposure?
A Lean, Wary Post-Bailout Ireland Begets Rising Stocks
at Investor's Business Daily - Fri Feb 14, 4:17PM CST
At the start of this year, Ireland's stock markets were worth about half of what they were at the end of 2006, according to Credit Suisse. In 2007, Ireland was the European Union's second wealthiest country in GDP per capita, and the fifth richest in...
S&P Upgrades Ireland Outlook: Time for the Irish ETF? - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jul 23, 9:30AM CDT
Standard and Poor's is a little more optimistic on Ireland, should you be as well?
3 European ETFs Holding Their Ground - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Thu Jun 13, 2:30PM CDT
Global markets might be sliding, but these European ETFs have been holding up quite well.
Are European Stocks Oversold?
Ron DeLegge - ETFG - Tue Mar 26, 12:13AM CDT
Before you buy into the claim that stocks in the Eurozone are oversold, let's examine the facts. Do valuations and performance figures support these claims?